These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 32780430)

  • 1. Chemotherapy-induced peripheral neuropathy: Identifying the research gaps and associated changes to clinical trial design.
    St Germain DC; O'Mara AM; Robinson JL; Torres AD; Minasian LM
    Cancer; 2020 Oct; 126(20):4602-4613. PubMed ID: 32780430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of high-risk drugs related to chemotherapy-induced peripheral neuropathy in Cancer Therapy Evaluation Program-sponsored phase I trials.
    Kishimoto S; Oshima N; Rinker M; Krishna MC; Takebe N
    Eur J Cancer; 2019 Jul; 115():111-119. PubMed ID: 31132741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The National Cancer Institute Clinical Trials Planning Meeting for Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy.
    Dorsey SG; Kleckner IR; Barton D; Mustian K; O'Mara A; St Germain D; Cavaletti G; Danhauer SC; Hershman DL; Hohmann AG; Hoke A; Hopkins JO; Kelly KP; Loprinzi CL; McLeod HL; Mohile S; Paice J; Rowland JH; Salvemini D; Segal RA; Smith EL; Stevens WM; Janelsins MC
    J Natl Cancer Inst; 2019 Jun; 111(6):531-537. PubMed ID: 30715378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Comparative Review of Chemotherapy-Induced Peripheral Neuropathy in In Vivo and In Vitro Models.
    Eldridge S; Guo L; Hamre J
    Toxicol Pathol; 2020 Jan; 48(1):190-201. PubMed ID: 31331249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Goshajinkigan for prevention of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis.
    Kuriyama A; Endo K
    Support Care Cancer; 2018 Apr; 26(4):1051-1059. PubMed ID: 29280005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic review of acupuncture for chemotherapy-induced peripheral neuropathy.
    Li K; Giustini D; Seely D
    Curr Oncol; 2019 Apr; 26(2):e147-e154. PubMed ID: 31043820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy-induced peripheral neuropathy (CIPN) and its treatment: an NIH Collaboratory study of claims data.
    Gewandter JS; Kleckner AS; Marshall JH; Brown JS; Curtis LH; Bautista J; Dworkin RH; Kleckner IR; Kolb N; Mohile SG; Mustian KM
    Support Care Cancer; 2020 Jun; 28(6):2553-2562. PubMed ID: 31494735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological and Nonpharmacological Management of Chemotherapy-Induced Peripheral Neuropathy: A Scoping Review of Randomized Controlled Trials.
    Jones KF; Wechsler S; Zulewski D; Wood L
    J Palliat Med; 2022 Jun; 25(6):964-995. PubMed ID: 35128938
    [No Abstract]   [Full Text] [Related]  

  • 9. Exploring the impact of a decision support algorithm to improve clinicians' chemotherapy-induced peripheral neuropathy assessment and management practices: a two-phase, longitudinal study.
    Knoerl R; Mazzola E; Hong F; Salehi E; McCleary N; Ligibel J; Reyes K; Berry DL
    BMC Cancer; 2021 Mar; 21(1):236. PubMed ID: 33676431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging pharmacological strategies for the management of chemotherapy-induced peripheral neurotoxicity (CIPN), based on novel CIPN mechanisms.
    Argyriou AA; Bruna J; Park SB; Cavaletti G
    Expert Rev Neurother; 2020 Oct; 20(10):1005-1016. PubMed ID: 32667212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the efficacy of an electronic symptom assessment and self-care intervention to preserve physical function in individuals receiving neurotoxic chemotherapy.
    Knoerl R; Weller E; Halpenny B; Berry D
    BMC Cancer; 2018 Dec; 18(1):1203. PubMed ID: 30514351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A longitudinal examination of associations between age and chemotherapy-induced peripheral neuropathy in patients with gynecologic cancer.
    Bulls HW; Hoogland AI; Kennedy B; James BW; Arboleda BL; Apte S; Chon HS; Small BJ; Gonzalez BD; Jim HSL
    Gynecol Oncol; 2019 Feb; 152(2):310-315. PubMed ID: 30558975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy-Induced Peripheral Neuropathy: Causative Agents, Preventative Strategies, and Treatment Approaches.
    Kachrani R; Santana A; Rogala B; Pawasauskas J
    J Pain Palliat Care Pharmacother; 2020 Sep; 34(3):141-152. PubMed ID: 32118502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Goshajinkigan for reducing chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis.
    Hoshino N; Ganeko R; Hida K; Sakai Y
    Int J Clin Oncol; 2018 Jun; 23(3):434-442. PubMed ID: 29270698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin-norepinephrine reuptake inhibitors for the management of chemotherapy-induced peripheral neuropathy.
    Aziz MT; Good BL; Lowe DK
    Ann Pharmacother; 2014 May; 48(5):626-32. PubMed ID: 24577146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation by Ozone Therapy of Oxidative Stress in Chemotherapy-Induced Peripheral Neuropathy: The Background for a Randomized Clinical Trial.
    Clavo B; Martínez-Sánchez G; Rodríguez-Esparragón F; Rodríguez-Abreu D; Galván S; Aguiar-Bujanda D; Díaz-Garrido JA; Cañas S; Torres-Mata LB; Fabelo H; Téllez T; Santana-Rodríguez N; Fernández-Pérez L; Marrero-Callico G
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33802143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis, management, and evaluation of chemotherapy-induced peripheral neuropathy.
    Hausheer FH; Schilsky RL; Bain S; Berghorn EJ; Lieberman F
    Semin Oncol; 2006 Feb; 33(1):15-49. PubMed ID: 16473643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for chemotherapy-induced peripheral neuropathy in patients receiving taxane- and platinum-based chemotherapy.
    Molassiotis A; Cheng HL; Leung KT; Li YC; Wong KH; Au JSK; Sundar R; Chan A; Ng TR; Suen LKP; Chan CW; Yorke J; Lopez V
    Brain Behav; 2019 Jun; 9(6):e01312. PubMed ID: 31063261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Herbal medicines and chemotherapy induced peripheral neuropathy (CIPN): A critical literature review.
    Schloss J; Colosimo M; Vitetta L
    Crit Rev Food Sci Nutr; 2017 Apr; 57(6):1107-1118. PubMed ID: 25849070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanistic insights into the pathogenesis of microtubule-targeting agent-induced peripheral neuropathy from pharmacogenetic and functional studies.
    Chua KC; El-Haj N; Priotti J; Kroetz DL
    Basic Clin Pharmacol Toxicol; 2022 Jan; 130 Suppl 1(Suppl 1):60-74. PubMed ID: 34481421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.